Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors
- 1 April 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (8) , 2293-2298
- https://doi.org/10.1016/j.bmcl.2006.01.028
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase: Synthesis, Preliminary SAR, and Biological ActivitiesJournal of Medicinal Chemistry, 2005
- G2 checkpoint abrogators as anticancer drugsMolecular Cancer Therapeutics, 2004
- Identification of Compounds with Nanomolar Binding Affinity for Checkpoint Kinase-1 Using Knowledge-Based Virtual ScreeningJournal of Medicinal Chemistry, 2004
- Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging AgentsJournal of Biological Chemistry, 2003
- Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25ACancer Cell, 2003
- Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G 2 checkpointsProceedings of the National Academy of Sciences, 2002
- Targeting Serine / Threonine Protein Kinase B / Akt and Cell-cycle Checkpoint Kinases for Treating CancerCurrent Topics in Medicinal Chemistry, 2002
- Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory NeoplasmsJournal of Clinical Oncology, 2001
- Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzimidazolone derivativesJournal of Medicinal Chemistry, 1987